Evidence map›Paper›PMID 41179105›Full record

ArticleCureus2025

A Case of 17β-Hydroxysteroid Dehydrogenase Type 10 (HSD10) Disease Caused by a Novel Variant Presenting With Rapidly Progressive Cardiomyopathy Triggered by Viral Infection.

Ryusei Kubo, Yoichi Iwamoto, Sayaka Ajihara, Kei Murayama, Akira Ohtake, Sumie Fujinuma, Koki Sugiyama, Hirotaka Ishido, Seigo Korematsu, Satoshi Masutani

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ryusei KuboPediatrics, Saitama Medical Center, Saitama Medical University, Kawagoe, JPN.
Yoichi IwamotoPediatrics, Saitama Medical Center, Saitama Medical University, Kawagoe, JPN.
Sayaka AjiharaPediatrics and Clinical Genomics, Saitama Medical University Hospital, Iruma, JPN.
Kei MurayamaDiagnostics and Therapeutics of Intractable Diseases, Intractable Disease Research Center, Graduate School of Medicine, Juntendo University, Tokyo, JPN.
Akira OhtakePediatrics and Clinical Genomics, Saitama Medical University Hospital, Iruma, JPN.
Sumie FujinumaPediatrics, Saitama Medical Center, Saitama Medical University, Kawagoe, JPN.
Koki SugiyamaPediatrics, Saitama Medical Center, Saitama Medical University, Kawagoe, JPN.
Hirotaka IshidoPediatrics, Saitama Medical Center, Saitama Medical University, Kawagoe, JPN.
Seigo KorematsuPediatrics, Saitama Medical Center, Saitama Medical University, Kawagoe, JPN.
Satoshi MasutaniPediatrics, Saitama Medical Center, Saitama Medical University, Kawagoe, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human 17β-hydroxysteroid dehydrogenase type 10 (HSD10) is a rare X-linked mitochondrial disorder caused by mutations in the

Indexed as

cardiomyopathyhsd10 diseasehsd17b10mitochondrial disorderval12metvariant

Identifiers

PMID41179105
PMCPMC12576361

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.